Moxifloxacin Sandoz (Moxifloxacin)

Moxifloxacin is indicated for several bacterial infections that affect the respiratory tract and skin.

• Community‑acquired pneumonia: eradicates the causative pathogens and improves clinical recovery.
• Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting organisms.
• Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications.
• Skin and soft tissue infections: clears susceptible bacterial strains in cutaneous lesions.
• Other susceptible bacterial infections: provides targeted therapy where the organism is known to be sensitive.

• Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these targets, it prevents bacterial DNA supercoiling and separation, leading to bactericidal activity against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools, occasionally watery.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness.
• Abdominal pain: cramping or discomfort.
• Rash: mild skin irritation or redness.

Serious or Rare Side Effects

• Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon.
• QT interval prolongation: risk of cardiac arrhythmias.
• Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.
• Clostridioides difficile infection: severe colitis with diarrhea.
• Hepatic toxicity: elevated liver enzymes or jaundice.
• Photosensitivity: heightened skin reaction to sunlight.

Before prescribing Moxifloxacin, clinicians should consider patient‑specific factors and safety measures.

• Assess renal function: adjust therapy if renal impairment is present.
• Evaluate hypersensitivity: avoid in patients with known fluoroquinolone allergy.
• Monitor for tendon pain: discontinue if signs of tendon inflammation appear.
• Use cautiously in QT‑prolonging conditions: consider ECG monitoring.
• Avoid concomitant use with corticosteroids when possible: increased risk of tendon injury.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Moxifloxacin can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: reduce absorption of the drug.
• Warfarin: may increase anticoagulant effect and bleeding risk.
• Corticosteroids: heightened risk of tendon rupture.
• Theophylline: increased plasma levels leading to toxicity.
• Cyclosporine: elevated concentrations may cause nephrotoxicity.

Moderate Interactions (Monitor Closely)

• NSAIDs: may increase risk of central nervous system effects.
• Oral contraceptives: reduced effectiveness, consider alternative contraception.
• Diabetic agents: potential for altered glucose control.
• Statins: increased risk of myopathy.
• Antiarrhythmic drugs: possible additive QT prolongation.